{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:25:17Z","timestamp":1759335917770},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,4,27]],"date-time":"2014-04-27T00:00:00Z","timestamp":1398556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s10067-014-2625-z","type":"journal-article","created":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T00:24:48Z","timestamp":1398471888000},"page":"1481-1487","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Infliximab has no apparent effect in the inner ear hearing function of patients with rheumatoid arthritis and ankylosing spondylitis"],"prefix":"10.1007","volume":"33","author":[{"given":"H.","family":"Toktas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Okur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Dundar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dikici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. K.","family":"Kahveci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,27]]},"reference":[{"issue":"3","key":"2625_CR1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2217\/imt.13.10","volume":"5","author":"A Jain","year":"2013","unstructured":"Jain A, Singh JA (2013) Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature. Immunotherapy 5(3):265\u2013299","journal-title":"Immunotherapy"},{"key":"2625_CR2","first-page":"183","volume":"6","author":"M Savastano","year":"2010","unstructured":"Savastano M, Marioni G, Giacomelli L, Ramonda R, Ferraro SM, Punzi L (2010) Sensorineural hearing loss in ankylosing spondylitis treated with TNF blockers. B-ENT 6:183\u2013188","journal-title":"B-ENT"},{"key":"2625_CR3","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1177\/000348940411300703","volume":"113","author":"BF McCabe","year":"1979","unstructured":"McCabe BF (1979) Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 113:526\u2013530","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2625_CR4","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00296-007-0373-y","volume":"27","author":"Z Touma","year":"2007","unstructured":"Touma Z, Nawwar R, Hadi U, Hourani M, Arayssi T (2007) The use of TNF blockers in Cogan\u2019s syndrome. Rheumatol Int 27:995\u2013996","journal-title":"Rheumatol Int"},{"key":"2625_CR5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00296-006-0252-y","volume":"27","author":"M Fricker","year":"2007","unstructured":"Fricker M, Baumann A, Wermelinger F, Villiger PM, Helbling A (2007) A novel therapeutic option in Cogan diseases? TNF-alpha blockers. Rheumatol Int 27:493\u2013495","journal-title":"Rheumatol Int"},{"issue":"6","key":"2625_CR6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/000348940811700611","volume":"117","author":"DH Lee","year":"2008","unstructured":"Lee DH, Yeo SW, Chang KH, Park SY, Oh JH, Seo JH (2008) Effect of infliximab on experimentally induced otitis media in rats. Ann Otol Rhinol Laryngol 117(6):470\u2013476","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2625_CR7","first-page":"86","volume":"54","author":"K Lamm","year":"1998","unstructured":"Lamm K, Lamm H, Arnold W (1998) Effect of hyperbaric oxygen therapy in comparison to conventional or placebo therapy or no treatment in idiopathic sudden hearing loss, acoustic trauma, noise-induced hearing loss and tinnitus. A literature survey. Adv Otorhinolaryngol 54:86\u201399","journal-title":"Adv Otorhinolaryngol"},{"issue":"Suppl 1","key":"2625_CR8","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1478-6354-13-S1-S2","volume":"13","author":"JS Smollen","year":"2011","unstructured":"Smollen JS, Infliximab EP (2011) 12\u00a0years of experience. Arthritis Res Ther 13(Suppl 1):S2","journal-title":"Arthritis Res Ther"},{"key":"2625_CR9","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","volume":"344","author":"EH Choy","year":"2001","unstructured":"Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344:907\u2013916","journal-title":"N Engl J Med"},{"key":"2625_CR10","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(94)90628-9","volume":"344","author":"MJ Elliott","year":"1994","unstructured":"Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, Woody JN (1994) Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105\u20131110","journal-title":"Lancet"},{"key":"2625_CR11","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/art.10274","volume":"46","author":"PG Conaghan","year":"2002","unstructured":"Conaghan PG, Quinn MA, O\u2019Connor P, Wakefield RJ, Karim Z, Emery P (2002) Can very high-dose anti-tumor necrosis factor blockade at onset of rheumatoid arthritis produce long-term remission? Arthritis Rheum 46:1971\u20131972","journal-title":"Arthritis Rheum"},{"key":"2625_CR12","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/art.21790","volume":"54","author":"J Braun","year":"2006","unstructured":"Braun J, Landew\u00e9 R, Hermann K-G, Han J, Yan S, Williamson P, van der Heijde D (2006) ASSERT Study Group: major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo controlled magnetic resonance imaging study. Arthritis Rheum 54:1646\u20131652","journal-title":"Arthritis Rheum"},{"issue":"Suppl 28","key":"2625_CR13","first-page":"S152","volume":"20","author":"C Antoni","year":"2002","unstructured":"Antoni C, Braun J (2002) Side effects of anti-TNF therapy: current knowledge. Clin Exp Rheumatol 20(Suppl 28):S152\u2013S157","journal-title":"Clin Exp Rheumatol"},{"key":"2625_CR14","first-page":"3","volume":"243","author":"A Axelsson","year":"1968","unstructured":"Axelsson A (1968) The vascular anatomy of the cochlea in the guinea pig and in man. Acta Otolaryngol Suppl 243:3","journal-title":"Acta Otolaryngol Suppl"},{"key":"2625_CR15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0165-0173(03)00189-9","volume":"43","author":"T Nakashima","year":"2003","unstructured":"Nakashima T, Naganawa S, Some M et al (2003) Disorders of cochlear blood flow. Brain Res Rev 43:17\u201328","journal-title":"Brain Res Rev"},{"key":"2625_CR16","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1161\/STROKEAHA.110.593327","volume":"41","author":"EQ Scherer","year":"2010","unstructured":"Scherer EQ, Yang J, Canis M et al (2010) Tumor necrosis factor alpha enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling. Stroke 41:2618\u20132624","journal-title":"Stroke"},{"key":"2625_CR17","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00405-006-0027-9","volume":"263","author":"D Lobo","year":"2006","unstructured":"Lobo D, Trinidad A, Garcia-Berrocal JR, Verdaguer JM, Ramirez-Camacho R (2006) TNF-alpha blockers do not improve the hearing recovery obtained with glucocorticoid in an autoimmune experimental labyrinthitis. Eur Arch Otorhinolaryngol 263:622\u2013626","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1\u20132","key":"2625_CR18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0378-5955(02)00330-1","volume":"167","author":"A Job","year":"2002","unstructured":"Job A, Nottet JB (2002) DPOAEs in young normal-hearing subjects with histories of otitis media: evidence of sub-clinical impairments. Hear Res 167(1\u20132):28\u201332","journal-title":"Hear Res"},{"issue":"12","key":"2625_CR19","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/MLG.0b013e31813e6041","volume":"117","author":"E Okur","year":"2007","unstructured":"Okur E, Kilinc M, Yildirim I, Kilic MA, Tolun FI (2007) Effect of N-acetylcysteine on carboplatin-induced ototoxicity and nitric oxide levels in a rat model. Laryngoscope 117(12):2183\u20132186","journal-title":"Laryngoscope"},{"issue":"7","key":"2625_CR20","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/000348941312200711","volume":"122","author":"F Ihler","year":"2013","unstructured":"Ihler F, Sharaf K, Bertlich M, Strieth S, Reichel CA, Berghaus A, Canis M (2013) Etanercept prevents decrease of cochlear blood flow dose-dependently caused by tumor necrosis factor alpha. Ann Otol Rhinol Laryngol 122(7):468\u2013473","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"11","key":"2625_CR21","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1017\/S002221511300217X","volume":"127","author":"RL Heywood","year":"2013","unstructured":"Heywood RL, Hadavi S, Donnelly S, Patel N (2013) Infliximab for autoimmune inner ear disease: case report and literature review. J Laryngol Otol 127(11):1145\u20131147","journal-title":"J Laryngol Otol"},{"issue":"3","key":"2625_CR22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.otorri.2012.04.008","volume":"64","author":"D Lobo","year":"2013","unstructured":"Lobo D, Garc\u00eda-Berrocal JR, Trinidad A, Verdaguer JM, Ram\u00edrez-Camachob R (2013) Review of the biological agents used for immune-mediated inner ear disease. Acta Otorrinolaringol Esp 64(3):223\u2013229","journal-title":"Acta Otorrinolaringol Esp"},{"issue":"2","key":"2625_CR23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000331945","volume":"17","author":"A Belinchon","year":"2012","unstructured":"Belinchon A, Perez-Garrigues H, Tenias JM (2012) Evolution of symptoms in M\u00e9ni\u00e8re\u2019s disease. Audiol Neuro Otol 17(2):126\u2013132","journal-title":"Audiol Neuro Otol"},{"key":"2625_CR24","first-page":"82","volume-title":"Ototoxicity","author":"C Rotstein","year":"2004","unstructured":"Rotstein C, Mandell L (2004) Clinical aminoglycoside ototoxicity. In: Roland PS, Rutka JA (eds) Ototoxicity. BC Decker Inc, Canada, pp 82\u201393"},{"issue":"6","key":"2625_CR25","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/AUD.0b013e31818005a4","volume":"29","author":"CM Schmidt","year":"2008","unstructured":"Schmidt CM, Knief A, Lagosch AK, Deuster D, Am Zehnhoff-Dinnesen A (2008) Left-right asymmetry in hearing loss following cisplatin therapy in children-the left ear is slightly but significantly more affected. Ear Hear 29(6):830\u2013837","journal-title":"Ear Hear"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2625-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2625-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2625-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T11:16:13Z","timestamp":1597749373000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2625-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,27]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["2625"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2625-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,27]]}}}